PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.08. PURE Bioscience shares last traded at $0.08, with a volume of 32,037 shares.
PURE Bioscience Stock Up 26.9 %
The company has a market cap of $9.39 million, a price-to-earnings ratio of -2.10 and a beta of 0.07. The company’s 50-day moving average is $0.08 and its 200 day moving average is $0.08.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings data on Monday, December 16th. The company reported ($0.01) earnings per share for the quarter.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- The 3 Best Retail Stocks to Shop for in August
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- How to Most Effectively Use the MarketBeat Earnings Screener
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
